NCT07557875

Brief Summary

This study aims to compare the wound healing efficacy and postoperative experiences between the 940 nm diode laser technique and the traditional electrosurgery method for treating ankyloglossia (tongue-tie) in children aged 3 to 6 years. Participants are randomly assigned to one of two groups: Experimental Group - Patients undergo lingual frenectomy using a 940 nm diode laser and Active Comparator Group - Patients undergo the procedure using conventional high-frequency electrosurgery. The study evaluates several key outcomes at multiple intervals (24 hours, 3 days, 1 week, and 1 month post-surgery), including: (1) Wound Healing: Measured by the Early Wound Healing Score (EHS); (2) Pain Levels: Assessed using the Wong-Baker FACES Pain Rating Scale; (3) Bleeding Control: Evaluation of intraoperative bleeding; (4) Tongue Mobility: Measurement of free tongue length according to Kotlow's classification. The goal is to determine if the diode laser provides superior healing, less pain, and better bleeding control compared to electrosurgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Oct 2024Oct 2026

Study Start

First participant enrolled

October 1, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 22, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 30, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 22, 2026

Last Update Submit

April 22, 2026

Conditions

Keywords

AnkyloglossiaTongue-tieLingual frenectomyDiode laserElectrosurgeryWound healingPostoperative painEarly Wound Healing Score (EHS)Wong-Baker FACES Pain Rating ScaleKotlow's classification

Outcome Measures

Primary Outcomes (1)

  • Early Wound Healing Score (EHS)

    The EHS is used to evaluate the early healing of periodontal soft tissue wounds. It is the sum of three components: Clinical Signs of Re-epithelialization (CSR), Clinical Signs of Haemostasis (CSH), and Clinical Signs of Inflammation (CSI). The total score ranges from 0 to 10, where a higher score indicates better and faster wound healing (10 being perfect healing).

    24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.

Secondary Outcomes (3)

  • Pain Intensity assessed by Wong-Baker FACES Pain Rating Scale

    24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.

  • Level of Intraoperative Bleeding

    During the surgical procedure (T0)

  • Increase in Free Tongue Length

    Baseline (T0), 1 week (T3), and 1 month (T4) post-surgery.

Study Arms (2)

Diode Laser Group

EXPERIMENTAL

Patients in this group undergo lingual frenectomy using a 940 nm diode laser (Epic X, Biolase). The procedure is performed using a transverse incision technique without suturing. Laser settings include an average power of 1W, peak power of 2W in pulsed mode (CP2), and a 940 nm wavelength.

Procedure: Lingual Frenectomy using 940nm Diode Laser

Electrosurgery Group

ACTIVE COMPARATOR

Patients in this group undergo lingual frenectomy using a high-frequency electrosurgical unit (ERBE-VIO 100C). The procedure follows the same transverse incision protocol without suturing as the experimental group.

Procedure: Lingual Frenectomy using High-frequency Electrosurgery

Interventions

Lingual frenectomy performed using a 940 nm Diode Laser (Epic X, Biolase). The laser is set to pulsed mode (CP2), average power 1W, and peak power 2W. The procedure involves a transverse incision to release the frenum without suturing. Protective eyewear is mandatory for the patient and surgical team.

Also known as: Diode Laser Frenectomy, Laser-assisted Frenotomy
Diode Laser Group

Lingual frenectomy performed using a high-frequency electrosurgical unit (ERBE-VIO 100C). The procedure follows a standardized transverse incision protocol without suturing. A grounding pad (electrode) is applied to the patient's body to complete the circuit. This serves as the active comparator representing the conventional surgical method at the hospital.

Also known as: Electrosurgical Frenectomy, Electrocautery Frenotomy
Electrosurgery Group

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients aged between 3 and 6 years.
  • Diagnosed with grade 3 or grade 4 ankyloglossia according to Kotlow's classification (1999).
  • Parents or legal guardians provide informed consent for the child to participate in the study.
  • Patients and guardians agree to follow the follow-up schedule (24 hours, 3 days, 1 week, and 1 month post-surgery).

You may not qualify if:

  • History of allergy to local anesthetics (e.g., Lidocaine, Adrenaline).
  • Patients with systemic diseases or high-risk surgical factors (e.g., cardiovascular disease, bleeding disorders, hemophilia, epilepsy, or uncontrolled asthma).
  • Uncooperative patients who are unable to undergo the procedure under local anesthesia or fail to follow post-operative instructions.
  • Patients who withdraw from the study before completion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Children's Hospital 1, Department of Odonto-Stomatology

Ho Chi Minh City, Vietnam

RECRUITING

Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, Vietnam

RECRUITING

Related Publications (3)

  • Kotlow LA. Ankyloglossia (tongue-tie): a diagnostic and treatment quandary. Quintessence Int. 1999 Apr;30(4):259-62.

    PMID: 10635253BACKGROUND
  • Hwang WB, Kim DJ, Oh GS, Park JH. Aryl Hydrocarbon Receptor Ligands Indoxyl 3-sulfate and Indole-3-carbinol Inhibit FMS-like Tyrosine Kinase 3 Ligand-induced Bone Marrow-derived plasmacytoid Dendritic Cell Differentiation. Immune Netw. 2018 Oct 23;18(5):e35. doi: 10.4110/in.2018.18.e35. eCollection 2018 Oct.

    PMID: 30402330BACKGROUND
  • Mazzoni A, Navarro RS, Fernandes KPS, Mesquita-Ferrari RA, Horliana ACRT, Silva T, Santos EM, Sobral APT, Junior AB, Nammour S, Motta LJ, Bussadori SK. Comparison of the Effects of High-Power Diode Laser and Electrocautery for Lingual Frenectomy in Infants: A Blinded Randomized Controlled Clinical Trial. J Clin Med. 2022 Jun 30;11(13):3783. doi: 10.3390/jcm11133783.

    PMID: 35807068BACKGROUND

Related Links

MeSH Terms

Conditions

AnkyloglossiaHyperthermiaPain, Postoperative

Interventions

Lasers, Semiconductor

Condition Hierarchy (Ancestors)

Stomatognathic DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsHeat Stress DisordersWounds and InjuriesPostoperative ComplicationsPathologic ProcessesPainNeurologic Manifestations

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Central Study Contacts

Phong Dai Lam, PhD, DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The study is designed as a single-blind trial to minimize bias in outcome assessment. The masking procedures are implemented as follows: * Participants and Legal Guardians: To maintain masking, the surgical procedures are performed under similar clinical settings. The specific equipment (Diode Laser or Electrosurgical unit) is not disclosed to the children or their parents before, during, or after the procedure. * Outcomes Assessor: A dedicated evaluator, who is responsible for measuring the free tongue length, assessing pain levels via the Wong-Baker scale, and calculating the Early Wound Healing Score (EHS), is strictly masked to the treatment allocation. This assessor is not present during the surgery and only performs evaluations at scheduled follow-up intervals. * Data Analyst: The individuals involved in the statistical analysis will process the data using coded group identifiers (e.g., Group 1 and Group 2) without knowledge of which code corresponds to the laser or electrosurger
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study utilizes a parallel-group, randomized clinical trial design with a 1:1 allocation ratio. Participants are assigned to either the experimental group or the control group using a simple randomization method (drawing lots). * Randomization: A total of 50 lots are prepared, divided into two equal sets marked with numbers "1" and "2". Each participant draws one lot to determine their treatment group. * Allocation: Group 1 (Experimental): Participants who draw lot "1" undergo lingual frenectomy using a 940 nm diode laser. Group 2 (Control): Participants who draw lot "2" undergo the procedure using high-frequency electrosurgery. * Blinding: This is a single-blind study. Participants and their legal guardians are blinded to the assigned surgical method. To ensure objective results, the outcome evaluator is also blinded to the participant's treatment group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department of Oral and Maxillofacial Radiology, Faculty of Dentistry

Study Record Dates

First Submitted

April 22, 2026

First Posted

April 30, 2026

Study Start

October 1, 2024

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

The individual participant data will not be shared to ensure absolute confidentiality for the pediatric patients and their families, as stated in the informed consent and study protocol approved by the Ethics Committee.

Locations